Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Adrenal disorders can cause lasting brain and behavior issues in children.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Fat injections in the face can cause hair loss.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.